Lin EP - Search Results

1

Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors.

Lin EP, Huang LC, Whisenant J, York S, Osterman T, Lewis J, Iams W, Skotte E, Cass A, Hsu CY, Shyr Y, Horn L. Lin EP, et al. ERJ Open Res. 2022 Oct 10;8(4):00684-2021. doi: 10.1183/23120541.00684-2021. eCollection 2022 Oct. ERJ Open Res. 2022. PMID: 36225333 Free PMC article.

2

Das S, Ciombor KK, Haraldsdottir S, Pumpalova Y, Sahin IH, Pineda G, Shyr Y, Lin EP, Hsu CY, Chu SK, Goff LW, Cardin DB, Bilen MA, Fisher GA, Wu C, Berlin J. Das S, et al. Among authors: lin ep. Oncologist. 2020 Aug;25(8):669-679. doi: 10.1634/theoncologist.2019-0637. Epub 2020 Jan 14. Oncologist. 2020. PMID: 31943525 Free PMC article.

3

Mortality of Cardiovascular Events in Patients With COPD and Preceding Hospitalization for Acute Exacerbation.

Wang M, Lin EP, Huang LC, Li CY, Shyr Y, Lai CH. Wang M, et al. Among authors: lin ep. Chest. 2020 Sep;158(3):973-985. doi: 10.1016/j.chest.2020.02.046. Epub 2020 Mar 14. Chest. 2020. PMID: 32184108

4

Development and Evaluation of a Method to Correct Misinterpretation of Clinical Trial Results With Long-term Survival.

Hsu CY, Lin EP, Shyr Y. Hsu CY, et al. Among authors: lin ep. JAMA Oncol. 2021 Jul 1;7(7):1041-1044. doi: 10.1001/jamaoncol.2021.0289. JAMA Oncol. 2021. PMID: 33856410 Free PMC article.

5

Analysis of Cancer Survival Associated With Immune Checkpoint Inhibitors After Statistical Adjustment: A Systematic Review and Meta-analyses.

Lin EP, Hsu CY, Berry L, Bunn P, Shyr Y. Lin EP, et al. JAMA Netw Open. 2022 Aug 1;5(8):e2227211. doi: 10.1001/jamanetworkopen.2022.27211. JAMA Netw Open. 2022. PMID: 35976648 Free PMC article.

6

Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit.

Lin EP, Hsu CY, Chiou JF, Berry L, Horn L, Bunn P, Yang JC, Yang PC, Adjei AA, Shyr Y. Lin EP, et al. J Thorac Oncol. 2022 Dec;17(12):1365-1374. doi: 10.1016/j.jtho.2022.08.010. Epub 2022 Aug 30. J Thorac Oncol. 2022. PMID: 36049656 Free PMC article.

7

PINK1-Mediated Inhibition of EGFR Dimerization and Activation Impedes EGFR-Driven Lung Tumorigenesis.

Lin EP, Huang BT, Lai WY, Tseng YT, Yang SC, Kuo HC, Yang PC. Lin EP, et al. Cancer Res. 2021 Apr 1;81(7):1745-1757. doi: 10.1158/0008-5472.CAN-20-2582. Epub 2021 Feb 11. Cancer Res. 2021. PMID: 33574089

8

Population-Based Cohort Study Reveals Distinct Associations Between Female Lung Cancer and Breast Cancer in Taiwan.

Lin EP, Lin CH, Yang CY, Lu TP, Chang SN, Hsiao TH, Huang BT, Yu CJ, Chan KA, Yang PC. Lin EP, et al. Among authors: lin ch. JCO Clin Cancer Inform. 2018 Dec;2:1-14. doi: 10.1200/CCI.18.00065. JCO Clin Cancer Inform. 2018. PMID: 30652619

9

AptBCis1, An Aptamer-Cisplatin Conjugate, Is Effective in Lung Cancer Leptomeningeal Carcinomatosis.

Huang BT, Lai WY, Yeh CL, Tseng YT, Peck K, Yang PC, Lin EP. Huang BT, et al. Among authors: lin ep. ACS Nano. 2024 Oct 15;18(41):27905-27916. doi: 10.1021/acsnano.4c04680. Epub 2024 Oct 3. ACS Nano. 2024. PMID: 39360769 Free PMC article.

10

A Novel TNF-α-Targeting Aptamer for TNF-α-Mediated Acute Lung Injury and Acute Liver Failure.

Lai WY, Wang JW, Huang BT, Lin EP, Yang PC. Lai WY, et al. Among authors: lin ep. Theranostics. 2019 Feb 28;9(6):1741-1751. doi: 10.7150/thno.30972. eCollection 2019. Theranostics. 2019. PMID: 31037135 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters